HerbertDavidAronowMDMPH

Cardiology • Ypsilanti, MI

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine, Cardiac Critical Care

Medical Director, Heart & Vascular Service Line Henry Ford Health

Join to view full profile

Dr. Aronow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aronow's full profile

Already have an account?

Office
5325 Elliott Dr
Ste 203
Ypsilanti, MI 48197
Phone+1 734-712-8000

Fax+1 734-712-8000

Education & Training

Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2003
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2001
University of MichiganResidency, Internal Medicine, 1994 - 1997
University of MichiganInternship, Internal Medicine, 1994 - 1995
University of Michigan Medical SchoolClass of 1994

Certifications & Licensure

MI State Medical License 1996 - 2027
RI State Medical License 2015 - 2022
PA State Medical License 2003 - 2011
OH State Medical License 2000 - 2003
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
AOA Board of Internal Medicine Interventional Cardiology (CAQ)

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Fellow (FSCAI) Society for Cardiovascular Angiography and Intervention, 2005
Fellow (SVM) Society for Vascular Medicine, 2005
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Carotid Revascularization Endarterectomy Versus Stenting Trial Start of enrollment: 2000 Dec 01
Completed
Not Applicable
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions Start of enrollment: 2004 Apr 01
Completed
Phase 3
Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE Start of enrollment: 2004 Oct 01
Completed
Not Applicable
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Start of enrollment: 2005 Nov 01
Completed
Phase 4
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy Start of enrollment: 2006 Oct 01
Completed
CHOICE: Carotid Stenting For High Surgical-Risk Patients Start of enrollment: 2006 Oct 01
Completed
Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA Start of enrollment: 2007 May 01
Terminated
Phase 4
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety Start of enrollment: 2008 Jun 01
Completed
Not Applicable
Genotype Information and Functional Testing Study Start of enrollment: 2009 Oct 01
Completed
A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery Start of enrollment: 2010 Jul 01
Completed
Not Applicable
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents Start of enrollment: 2011 Jul 01
Completed
Phase 2
Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries Start of enrollment: 2011 Jul 01
Completed
Not Applicable
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) Start of enrollment: 2013 Oct 01
Active, not recruiting
ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Completed
Not Applicable
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia Start of enrollment: 2014 Aug 01
Completed
Not Applicable
Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge Start of enrollment: 2014 Aug 11
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

13 citations
Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States.
Dhaval Kolte, Charles Beale, Herbert D. Aronow, Kevin F. Kennedy, Eirini Apostolidou
The Journal of Thoracic and Cardiovascular Surgery. 2020-01-01
276 citations
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Böhm, Kazuomi Kario, David E. Kandzari, Felix Mahfoud, Michael A. Weber
Lancet. 2020-05-02
7 citations
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.
Rajesh V Swaminathan, Cara Anne East, Dmitriy N Feldman, Naomi D Fisher, Joseph M Garasic
Journal of the Society for Cardiovascular Angiography & Interventions. 2023-08-21

Journal Articles

WIRION Embolic Protection System in Lower Extremity Arterial Interventions
Herbert D Aronow, J Stephen Jenkins, Nicolas W Shammas, Lawrence A Garcia, Ehrin J Armstrong, ScienceDirect
Focus on Tricuspid, Mitral, and Aortic Valve Interventions Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights from the STS/ACC TVT Reg...
Sahil Khera, Sammy Elmariah, Dhaval Kolte, Sreekanth Vemulapalli, Herbert D Aronow, Igor F Palacios, Stephan Heo, Vinod H Thourani, J Dawn Abbott, Paul C Gordon, ScienceDirect

Press Mentions

Peripheral Matters | PAD: Putting the 2024 Guideline into PracticeAugust 30th, 2024
STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study YetOctober 29th, 2021
Society for Vascular Medicine Elects Dr. Herb Aronow as Its New PresidentJune 18th, 2021
Join now to see all